-
Symbol
-
TPST on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001 per share
-
Latest Disclosed Ownership
-
163K shares
-
Security Ownership
-
3.7%
Versant Vantage II, L.P. ownership in Tempest Therapeutics, Inc. Common Stock, par value $0.001 per share (TPST)
2025-08-13 - Versant Vantage II, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 163K shares of Tempest Therapeutics, Inc. Common Stock, par value $0.001 per share (TPST).
This represents 3.7% percent ownership of the company.
In their previous filing dated 2025-02-11, Versant Venture Capital VI, L.P. had reported owning 2.12M shares, indicating a decrease of -92.3% percent.